0074-2306 : Rinvoq 15 mg Oral Tablet, Extended Release

Labeler: Abbvie Inc.
Product Type: Human Prescription Drug
Drug Name:  Rinvoq
Dosage Form: Oral Tablet, Extended Release
Application #: NDA211675
Rev. Date: 

NDC Package Codes:

  • 0074-2306-30: 30 TABLET, EXTENDED RELEASE IN 1 BOTTLE (0074‑2306‑30)
  • 0074-2306-70: 14 TABLET, EXTENDED RELEASE IN 1 BOTTLE (0074‑2306‑70)

Active Ingredients:

  • Upadacitinib

Dosage Strength:

  • 15 mg


Scan the QR code below to easily reference this data in the future:

NDC 0074-2306 QR Code

< Prev: 0074-2282Next: 0074-2440 >

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 October 2019.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA